Abstract
Growth factors (GFs) are often a key component in tissue engineering and regenerative medicine approaches. In order to fully exploit the therapeutic potential of GFs, GF delivery vehicles have to meet a number of key design criteria such as providing localized delivery and mimicking the dynamic native GF expression levels and patterns. The use of biomaterials as delivery systems is the most successful strategy for controlled delivery and has been translated into different commercially available systems. However, the risk of side effects remains an issue, which is mainly attributed to insufficient control over the release profile. This book chapter reviews the current strategies, chemistries, materials and delivery vehicles employed to overcome the current limitations associated with GF therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312
Aniruddha Deshpande SBK, Bhongade ML (2014) A comparative evaluation of rhPDGF-BB + β-TCP and subepithelial connective tissue graft for the treatment of multiple gingival recession defects in humans. Periodontics Restor Dent 34(2):241–249
Arima Y, Iwata H (2007) Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers. Biomaterials 28(20):3074–3082
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279(13):12346–12354
Backer MV, Gaynutdinov TI, Patel V, Bandyopadhyaya AK, Thirumamagal BTS, Tjarks W, Barth RF, Claffey K, Backer JM (2005) Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol Cancer Ther 4(9):1423–1429
Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H (2009) The role of vascular endothelial growth factor in wound healing. J Surg Res 153(2):347–358
Barati D, Shariati SRP, Moeinzadeh S, Melero-Martin JM, Khademhosseini A, Jabbari E (2016) Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel. J Control Release 223:126–136
Barnard JA, Daniel Beauchamp R, Russell WE, Dubois RN, Coffey RJ (1995) Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108(2):564–580
Bayer EA, Gottardi R, Fedorchak MV, Little SR (2015) The scope and sequence of growth factor delivery for vascularized bone tissue regeneration. J Control Release 219:129–140
Béduneau A, Saulnier P, Benoit J-P (2007) Active targeting of brain tumors using nanocarriers. Biomaterials 28(33):4947–4967
Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8(3):235–253
Berlanga-Acosta J, Fernandez-Montequin J, Valdes-Perez C, Savigne-Gutierrez W, Mendoza-Mari Y, Garcia-Ojalvo A, Falcon-Cama V, Garcia Del Barco-Herrera D, Fernandez-Mayola M, Perez-Saad H, Pimentel-Vazquez E, Urquiza-Rodriguez A, Kulikovsky M, Guillen-Nieto G (2017) Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome. Biomed Res Int 2017:2923759
Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Vrahas MS, Bouxsein ML, Evans CH (2007) Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 14:1039
Bhattacharyya S, Wang H, Ducheyne P (2012) Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules. Acta Biomater 8(9):3429–3435
Bier E, De Robertis EM (2015) Embryo development. BMP gradients: a paradigm for morphogen-mediated developmental patterning. Science 348(6242):aaa5838
Bing M, Da-Sheng C, Zhao-Fan X, Dao-Feng B, Wei L, Zhi-Fang C, Qiang W, Jia H, Jia-Ke C, Chuan-An S, Yong-Hua S, Guo-An Z, Xiao-Hua H (2007) Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair Regen 15(6):795–799
Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C (2007) Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 59(6):454–477
Bose S, Tarafder S (2012) Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater 8(4):1401–1421
Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell–matrix communication: [Matrix Biology (2000) 569–580]. Matrix Biol 19(8):815–827
Burdick JA, Ward M, Liang E, Young MJ, Langer R (2006) Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 27(3):452–459
Byambaa B, Annabi N, Yue K, Trujillo-de Santiago G, Alvarez MM, Jia W, Kazemzadeh-Narbat M, Shin SR, Tamayol A, Khademhosseini A (2017) Bioprinted osteogenic and vasculogenic patterns for engineering 3D bone tissue. Adv Healthc Mater 6(16):1700015-n/a
Caplan AI, Correa D (2011) PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 29(12):1795–1803
Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11(6):471–491
Chan SY, Wong RW (2000) Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275(49):38693–38698
Chan SJ, Love C, Spector M, Cool SM, Nurcombe V, Lo EH (2017) Endogenous regeneration: engineering growth factors for stroke. Neurochem Int 107:57–65
Chappell JC, Song J, Burke CW, Klibanov AL, Price RJ (2008) Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small 4(10):1769–1777
Chatzinikolaidou M, Laub M, Rumpf H, Jennissen HP (2002) Biocoating of electropolished and ultra-hydrophilic titanium and cobalt chromium molybdenum alloy surfaces with proteins. Mater Werkst 33(12):720–727
Chen W, Palazzo A, Hennink WE, Kok RJ (2017) Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres. Mol Pharm 14(2):459–467
Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21(21):2155–2161
Chiu LLY, Weisel RD, Li R-K, Radisic M (2011) Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med 5(1):69–84
Chung Y-I, Tae G, Hong Yuk S (2006) A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 27(12):2621–2626
Cochran DL, Oh TJ, Mills MP, Clem DS, McClain PK, Schallhorn RA, McGuire MK, Scheyer ET, Giannobile WV, Reddy MS, Abou-Arraj RV, Vassilopoulos PJ, Genco RJ, Geurs NC, Takemura A (2016) A randomized clinical trial evaluating rh-FGF-2/β-TCP in periodontal defects. J Dent Res 95(5):523–530
Cohen S (2008) Origins of growth factors: NGF and EGF. J Biol Chem 283(49):33793–33797
Cohen S, Levi-Montalcini R (1957) Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180. Cancer Res 17(1):15–20
Copland MJ, Rades T, Davies NM, Baird MA (2005) Lipid based particulate formulations for the delivery of antigen. Immunol Cell Biol 83:97
Cornock R, Beirne S, Thompson B, Wallace GG (2014) Coaxial additive manufacture of biomaterial composite scaffolds for tissue engineering. Biofabrication 6(2):025002
Dai C, Guo H, Lu J, Shi J, Wei J, Liu C (2011) Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT. Biomaterials 32(33):8506–8517
Davoodi P, Ng WC, Yan WC, Srinivasan MP, Wang C-H (2016) Double-walled microparticles-embedded self-cross-linked, injectable, and antibacterial hydrogel for controlled and sustained release of chemotherapeutic agents. ACS Appl Mater Interfaces 8(35):22785–22800
De Biase P, Capanna R (2005) Clinical applications of BMPs. Injury 36(Suppl 3):S43–S46
de Boer WI, Schuller AG, Vermey M, van der Kwast TH (1994) Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 145(5):1199–1207
De Laporte L, Rice JJ, Tortelli F, Hubbell JA (2013) Tenascin C promiscuously binds growth factors via its sifth fibronectin type III-like domain. PLOS One 8(4):e62076
Dee KC, Puleo DA, Bizios R (2003) Biomaterials. An introduction to tissue-biomaterial interactions. Wiley, Hoboken, pp 1–13
Dong X, Wang Q, Wu T, Pan H (2007) Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 93(3):750–759
Duggirala SS, Mehta RC, Deluca PP (1996) Interaction of recombinant human bone morphogenetic protein-2 with poly (d,l Lactide-co-glycolide) microspheres. Pharm Dev Technol 1(1):11–19
Ehlert N, Hoffmann A, Luessenhop T, Gross G, Mueller PP, Stieve M, Lenarz T, Behrens P (2011) Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes. Acta Biomater 7(4):1772–1779
Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH (2005) Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 101(1):93–109
El Agha E, Kosanovic D, Schermuly RT, Bellusci S (2016) Role of fibroblast growth factors in organ regeneration and repair. Semin Cell Dev Biol 53:76–84
Eley JG, Mathew P (2007) Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles. J Microencapsul 24(3):225–234
Ennett AB, Kaigler D, Mooney DJ (2006) Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res Part A 79A(1):176–184
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund L-O, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P (2016) Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer’s Res Ther 8(1):30
Faustino C, Rijo P, Reis CP (2017) Nanotechnological strategies for nerve growth factor delivery: therapeutic implications in Alzheimer’s disease. Pharmacol Res 120:68–87
Fernández-Montequín JI, Betancourt BY, Leyva-Gonzalez G, Mola EL, Galán-Naranjo K, Ramírez-Navas M, Bermúdez-Rojas S, Rosales F, García-Iglesias E, Berlanga-Acosta J, Silva-Rodriguez R, Garcia-Siverio M, Martinez LH (2009) Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. Int Wound J 6(1):67–72
Food and Drug Adinistration (2008) Safety warning on becaplermin in regranex, pp 1–10
Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest 127(5):1600–1612
Fu YC, Nie H, Ho ML, Wang CK, Wang CH (2008) Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng 99(4):996–1006
Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327(1):1–23
García JR, Clark AY, García AJ (2016) Integrin-specific hydrogels functionalized with VEGF for vascularization and bone regeneration of critical-size bone defects. J Biomed Mater Res Part A 104(4):889–900
Gary EF, Sheldon L, Luis AS, Leo BS, Samuel EL (2013) The role of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in orthopaedic bone repair and regeneration. Curr Pharm Des 19(19):3384–3390
Ge Zhang YN, Wang X, Qingsong H, Suggs LJ, Zhang J (2007) Controlled release of stromal cell–derived factor-1alpha in situ increases C-kit+ Cell homing to the infarcted heart. Tissue Eng 13(8):2063–2071
Gessner A, Lieske A, Paulke BR, Müller RH (2002) Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54(2):165–170
Gessner A, Lieske A, Paulke B-R, Müller RH (2003) Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res Part A 65A(3):319–326
Gou ML, Huang MJ, Gou ML, Huang MJ, Qian ZY, Gou ML, Huang MJ, Qian ZY, Yang L, Gou ML, Huang MJ, Qian ZY, Yang L, Dai M, Li XY, Wang K, Wen YJ, Li J, Zhao X, Wei YQ (2007) Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier. Growth Factors 25(3):202–208
Gou M, Dai M, Gu Y, Li X, Wen Y, Yang L, Wang K, Wei Y, Qian Z (2008) Basic fibroblast growth factor loaded biodegradable PCL-PEG-PCL copolymeric nanoparticles: preparation, in vitro release and immunogenicity study. J Nanosci Nanotechnol 8(5):2357–2361
Grefte S, Kuijpers-Jagtman AM, Torensma R, Hoff JWV (2010) Skeletal muscle fibrosis: the effect of stromal-derived factor-1α-loaded collagen scaffolds. Regen Med 5(5):737–747
Guicheux J, Gauthier O, Aguado E, Pilet P, Couillaud S, Jegou D, Daculsi G, Heymann D (1998) Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J Bone Miner Res 13(4):739–748
Han Q, Sun W, Lin H, Zhao W, Gao Y, Zhao Y, Chen B, Xiao Z, Hu W, Li Y, Yang B, Dai J (2009) Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A 15(10):2927–2935
Hanft JR, Pollak RA, Barbul A, van Gils C, Kwon PS, Gray SM, Lynch CJ, Semba CP, Breen TJ (2008) Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care 17(1):30–37
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 351(9113):1393–1396
Hanzhe Z, Tatsushi K, Takeshi H, Kanji T, Kentaro D, Violeta L, Atsushi T, Toru Y, Satoshi H, Yoshio I, Akiyoshi O, Koji A (2008) Gelatin-siloxane hybrid scaffolds with vascular endothelial growth factor induces brain tissue regeneration. Curr Neurovasc Res 5(2):112–117
Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M (2001) Versican interacts with chemokines and modulates cellular responses. J Biol Chem 276(7):5228–5234
Holland TA, Tabata Y, Mikos AG (2003) In vitro release of transforming growth factor-β1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 91(3):299–313
Holland TA, Tabata Y, Mikos AG (2005) Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101(1):111–125
Holland TA, Bodde EWH, Cuijpers VMJI, Baggett LS, Tabata Y, Mikos AG, Jansen JA (2007) Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr Cartil 15(2):187–197
Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regı M (2004) Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 68(1):105–109
Hu K, Olsen BR (2016) The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 91:30–38
Hua N, Sun J (2008) Body distribution of poly(d,l-lactide-co-glycolide) copolymer degradation products in rats. J Mater Sci, Mater Med 19(10):3243–3248
Huang X, Brazel CS (2001) On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 73(2):121–136
Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736
Hyzy SL, Olivares-Navarrete R, Schwartz Z, Boyan BD (2012) BMP2 induces osteoblast apoptosis in a maturation state and noggin-dependent manner. J Cell Biochem 113(10):3236–3245
Ito Y (2008) Covalently immobilized biosignal molecule materials for tissue engineering. Soft Matter 4(1):46–56
Itoh N, Ornitz DM (2011) Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149(2):121–130
Jansen RG, Van Kuppevelt TH, Daamen WF, Kuijpers-Jagtman AM, Von den Hoff JW (2009) FGF-2-loaded collagen scaffolds attract cells and blood vessels in rat oral mucosa. J Oral Pathol Med 38(8):630–638
Jau-Ching W, Huang W-C, Chen Y-C, Tsung-Hsi T, Tsai Y-A, Huang S-F, Huang H-C, Cheng H (2011) Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial. J Neurosurg, Spine 15(3):216–227
Jayakumar A, Rajababu P, Rohini S, Butchibabu K, Naveen A, Reddy PK, Vidyasagar S, Satyanarayana D, Pavan Kumar S (2011) Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects. J Clin Periodontol 38(2):163–172
Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, Lee JH, Kim BS (2008) Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369(2):774–780
Kanczler JM, Ginty PJ, White L, Clarke NMP, Howdle SM, Shakesheff KM, Oreffo ROC (2010) The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31(6):1242–1250
Kawaguchi H, Jingushi S, Izumi T, Fukunaga M, Matsushita T, Nakamura T, Mizuno K, Nakamura T, Nakamura K (2007) Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose–escalation prospective trial on patients with osteotomy. J Orthop Res 25(4):480–487
Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ (2008) Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29(22):3245–3252
Kempen DHR, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJA (2009) Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30(14):2816–2825
Kenney NJ, Bowman A, Korach KS, Carl Barrett J, Salomon DS (2003) Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat 79(2):161–173
Kim S, Kang Y, Krueger CA, Sen M, Holcomb JB, Chen D, Wenke JC, Yang Y (2012) Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater 8(5):1768–1777
Kim HKW, Oxendine I, Kamiya N (2013) High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells. Bone 54(1):141–150
Kimura Y, Hokugo A, Takamoto T, Tabata Y, Kurosawa H (2008) Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping. Tissue Eng Part C, Methods 14(1):47–57
King WJ, Krebsbach PH (2012) Growth factor delivery: how surface interactions modulate release in vitro and in vivo. Adv Drug Deliv Rev 64(12):1239–1256
Kishimoto Y, Hirano S, Kitani Y, Suehiro A, Umeda H, Tateya I, Kanemaru S-i, Tabata Y, Ito J (2010) Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel. Laryngoscope 120(1):108–113
Kitamura M, Akamatsu M, Machigashira M, Hara Y, Sakagami R, Hirofuji T, Hamachi T, Maeda K, Yokota M, Kido J, Nagata T, Kurihara H, Takashiba S, Sibutani T, Fukuda M, Noguchi T, Yamazaki K, Yoshie H, Ioroi K, Arai T, Nakagawa T, Ito K, Oda S, Izumi Y, Ogata Y, Yamada S, Shimauchi H, Kunimatsu K, Kawanami M, Fujii T, Furuichi Y, Furuuchi T, Sasano T, Imai E, Omae M, Yamada S, Watanuki M, Murakami S (2011) FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res 90(1):35–40
Klotz BJ, Gawlitta D, Rosenberg AJWP, Malda J, Melchels FPW (2016) Gelatin-methacryloyl hydrogels: towards biofabrication-based tissue repair. Trends Biotechnol 34(5):394–407
Koch FP, Becker J, Terheyden H, Capsius B, Wagner W, On behalf of the Research Group of this Multicenter Clinical Trial (2010) A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto β-tricalcium phosphate for sinus lift augmentation. Clin Oral Implants Res 21(11):1301–1308
Koempel JA, Patt BS, O’Grady K, Wozney J, Toriumi DM (1998) The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone. J Biomed Mater Res 41(3):359–363
Koria P (2012) Delivery of growth factors for tissue regeneration and wound healing. BioDrugs 26(3):163–175
Kumagai M, Marui A, Tabata Y, Takeda T, Yamamoto M, Yonezawa A, Tanaka S, Yanagi S, Ito-Ihara T, Ikeda T, Murayama T, Teramukai S, Katsura T, Matsubara K, Kawakami K, Yokode M, Shimizu A, Sakata R (2016) Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia. Heart Vessel 31(5):713–721
Kuo YC, Chou PR (2014) Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin. J Pharm Sci 103(8):2484–2497
Kuo Y-C, Rajesh R (2017) Nerve growth factor-loaded heparinized cationic solid lipid nanoparticles for regulating membrane charge of induced pluripotent stem cells during differentiation. Mater Sci Eng: C 77:680–689
Kurakhmaeva KB, Voronina TA, Kapica IG, Kreuter J, Nerobkova LN, Seredenin SB, Balabanian VY, Alyautdin RN (2008) Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80. Bull Exp Biol Med 145(2):259–262
Lanza RP, Langer RS, Vacanti J (2007) Principles of tissue engineering. Elsevier Academic Press, Amsterdam
Lau TT, Wang DA (2011) Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11(2):189–197
Lauzon M-A, Daviau A, Marcos B, Faucheux N (2015) Nanoparticle-mediated growth factor delivery systems: a new way to treat Alzheimer’s disease. J Controll Release 206(Supplement C):187–205
Lee S-H, Shin H (2007) Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 59(4):339–359
Lee P-Y, Li Z, Huang L (2003) Thermosensitive hydrogel as a Tgf-β1 gene delivery vehicle enhances diabetic wound healing. Pharm Res 20(12):1995–2000
Lee J-Y, Kim K-H, Shin S-Y, Rhyu I-C, Lee Y-M, Park Y-J, Chung C-P, Lee S-J (2006) Enhanced bone formation by transforming growth factor-β1-releasing collagen/chitosan microgranules. J Biomed Mater Res Part A 76A(3):530–539
Lee JS, Go DH, Bae JW, Lee SJ, Park KD (2007) Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release, Off J Control Release Soc 117(2):204–209
Lee JS, Bae JW, Joung YK, Lee SJ, Han DK, Park KD (2008) Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 346(1–2):57–63
Lee F, Chung JE, Kurisawa M (2009) An injectable hyaluronic acid–tyramine hydrogel system for protein delivery. J Control Release 134(3):186–193
Lee K, Silva EA, Mooney DJ (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8(55):153–170
Lee HJ, Fernandes-Cunha GM, Putra I, Koh W-G, Myung D (2017) Tethering growth factors to collagen surfaces using copper-free click chemistry: surface characterization and in vitro biological response. ACS Appl Mater Interfaces 9(28):23389–23399
Leslie-Barbick JE, Shen C, Chen C, West JL (2010) Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses. Tissue Eng Part A 17(1–2):221–229
Li B, Davidson JM, Guelcher SA (2009) The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 30(20):3486–3494
Li F, Yu F, Xu X, Li C, Huang D, Zhou X, Ye L, Zheng L (2017) Evaluation of recombinant human FGF-2 and PDGF-BB in periodontal regeneration: a systematic review and meta-analysis. Sci Rep 7(1):65
Lissenberg-Thunnissen SN, de Gorter DJJ, Sier CFM, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271
Liu J-J, Wang C-Y, Wang J-G, Ruan H-J, Fan C-Y (2011) Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning. J Biomed Mater Res Part A 96A(1):13–20
Liu L, Deng D, Xing Y, Li S, Yuan B, Chen J, Xia N (2013) Activity analysis of the carbodiimide-mediated amine coupling reaction on self-assembled monolayers by cyclic voltammetry. Electrochim Acta 89:616–622
Liu Q, Huang Y, Lan Y, Zuo Q, Li C, Zhang Y, Guo R, Xue W (2017) Acceleration of skin regeneration in full-thickness burns by incorporation of bFGF-loaded alginate microspheres into a CMCS–PVA hydrogel. J Tissue Eng Regen Med 11(5):1562–1573
Lu S, Lam J, Trachtenberg JE, Lee EJ, Seyednejad H, van den Beucken JJJP, Tabata Y, Wong ME, Jansen JA, Mikos AG, Kasper FK (2014) Dual growth factor delivery from bilayered, biodegradable hydrogel composites for spatially-guided osteochondral tissue repair. Biomaterials 35(31):8829–8839
Maeda H, Wada N, Tomokiyo A, Monnouchi S, Akamine A (2013) Prospective potency of TGF-beta1 on maintenance and regeneration of periodontal tissue. Int Rev Cell Mol Biol 304:283–367
Marsell R, Einhorn TA (2009) The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 40:S4–S7
Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42(6):551–555
Martino MM, Hubbell JA (2010) The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J 24(12):4711–4721
Martino MM, Tortelli F, Mochizuki M, Traub S, Ben-David D, Kuhn GA, Müller R, Livne E, Eming SA, Hubbell JA (2011) Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 3(100):100ra189–100ra189
Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA (2013) Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci 110(12):4563–4568
Masters KS (2011) Covalent growth factor immobilization strategies for tissue repair and regeneration. Macromol Biosci 11(9):1149–1163
Matsuo T, Sugita T, Kubo T, Yasunaga Y, Ochi M, Murakami T (2003) Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res Part A 66A(4):747–754
McGuire MK, Scheyer ET, Schupbach P (2009) Growth factor–mediated treatment of recession defects: a randomized controlled trial and histologic and microcomputed tomography examination. J Periodontol 80(4):550–564
Miller RE, Grodzinsky AJ, Cummings K, Plaas AHK, Cole AA, Lee RT, Patwari P (2010) Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum 62(12):3686–3694
Mitchell AC, Briquez PS, Hubbell JA, Cochran JR (2016) Engineering growth factors for regenerative medicine applications. Acta Biomater 30:1–12
Moore NM, Lin NJ, Gallant ND, Becker ML (2010) The use of immobilized osteogenic growth peptide on gradient substrates synthesized via click chemistry to enhance MC3T3-E1 osteoblast proliferation. Biomaterials 31(7):1604–1611
Morgan AW, Chan LL, Sendemir-Urkmez A, Cunningham BT, Jamison RD (2010) Detection of growth factor binding to gelatin and heparin using a photonic crystal optical biosensor. Mater Sci Eng C 30(5):686–690
Morishita R, Makino H, Aoki M, Hashiya N, Yamasaki K, Azuma J, Taniyama Y, Sawa Y, Kaneda Y, Ogihara T (2011) Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arterioscler, Thromb, Vasc Biol 31(3):713–720
Moshfeghi AA, Peyman GA (2005) Micro- and nanoparticulates. Adv Drug Deliv Rev 57(14):2047–2052
Mulder G, Tallis AJ, Marshall VT, Mozingo D, Phillips L, Pierce GF, Chandler LA, Sosnowski BK (2009) Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a Phase 1/2 trial. Wound Repair Regen 17(6):772–779
Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, McAllister BS, Murphy KS, McClain PK, Nevins ML, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE (2005) Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 76(12):2205–2215
Nguyen AH, McKinney J, Miller T, Bongiorno T, McDevitt TC (2015) Gelatin methacrylate microspheres for controlled growth factor release. Acta Biomater 13:101–110
Niebuhr A, Henry T, Goldman J, Baumgartner I, van Belle E, Gerss J, Hirsch AT, Nikol S (2011) Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease. Gene Ther 19:264
Nof M, Shea LD (2002) Drug-releasing scaffolds fabricated from drug-loaded microspheres. J Biomed Mater Res 59(2):349–356
Ogiwara K, Nagaoka M, Cho C-S, Akaike T (2006) Effect of photo-immobilization of epidermal growth factor on the cellular behaviors. Biochem Biophys Res Commun 345(1):255–259
Oh KS, Han SK, Lee HS, Koo HM, Kim RS, Lee KE, Han SS, Cho SH, Yuk SH (2006) Core/shell nanoparticles with lecithin lipid cores for protein delivery. Biomacromolecules 7(8):2362–2367
Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Investig 113(4):516–527
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55(3):329–347
Park JS, Park K, Woo DG, Yang HN, Chung H-M, Park K-H (2008) PLGA microsphere construct coated with TGF-β 3 loaded nanoparticles for neocartilage formation. Biomacromolecules 9(8):2162–2169
Park CJ, Clark SG, Lichtensteiger CA, Jamison RD, Johnson AJW (2009a) Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomater 5(6):1926–1936
Park K-H, Lee DH, Na K (2009b) Transplantation of poly(N-isopropylacrylamide-co-vinylimidazole) hydrogel constructs composed of rabbit chondrocytes and growth factor-loaded nanoparticles for neocartilage formation. Biotechnol Lett 31(3):337–346
Patist CM, Mulder MB, Gautier SE, Maquet V, Jerome R, Oudega M (2004) Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials 25(9):1569–1582
Patterson J, Siew R, Herring SW, Lin ASP, Guldberg R, Stayton PS (2010) Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 31(26):6772–6781
Peattie RA, Pike DB, Yu B, Cai S, Shu XZ, Prestwich GD, Firpo MA, Fisher RJ (2008) Effect gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv 15(6):389–397
Perrimon N, Pitsouli C, Shilo BZ (2012) Signaling mechanisms controlling cell fate and embryonic patterning. Cold Spring Harb Perspect Biol 4(8):a005975
Pike DB, Cai S, Pomraning KR, Firpo MA, Fisher RJ, Shu XZ, Prestwich GD, Peattie RA (2006) Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27(30):5242–5251
Pilakka-Kanthikeel S, Atluri VSR, Sagar V, Saxena SK, Nair M (2013) Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study. PLOS One 8(4):e62241
Poldervaart MT, Gremmels H, van Deventer K, Fledderus JO, Öner FC, Verhaar MC, Dhert WJA, Alblas J (2014) Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture. J Control Release 184:58–66
Powell RJ, Goodney P, Mendelsohn FO, Moen EK, Annex BH (2010) Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. J Vasc Surg 52(6):1525–1530
Pulavendran S, Rose C, Mandal AB (2011) Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice. J Nanobiotechnol 9(1):15
Qiang W, Chaoqun L, Luna F, Jiahua S, Zhiqiang L, Ruifang L, Liwei S (2012) Heparinized magnetic mesoporous silica nanoparticles as multifunctional growth factor delivery carriers. Nanotechnology 23(48):485703
Raiche AT, Puleo DA (2004) In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 25(4):677–685
Rajan SS, Liu HY, Vu TQ (2008) Ligand-bound quantum dot probes for studying the molecular scale dynamics of receptor endocytic trafficking in live cells. ACS Nano 2(6):1153–1166
Rechendorff K, Hovgaard MB, Foss M, Zhdanov VP, Besenbacher F (2006) Enhancement of protein adsorption induced by surface roughness. Langmuir 22(26):10885–10888
Ribeiro MP, Morgado PI, Miguel SP, Coutinho P, Correia IJ (2013) Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mater Sci Eng: C 33(5):2958–2966
Roldán JC, Detsch R, Schaefer S, Chang E, Kelantan M, Waiss W, Reichert TE, Gurtner GC, Deisinger U (2010) Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J Cranio-Maxillofac Surg 38(6):423–430
Roy H, Bhardwaj S, Yla-Herttuala S (2006) Biology of vascular endothelial growth factors. FEBS Lett 580(12):2879–2887
Ruhe PQ, Hedberg EL, Padron NT, Spauwen PHM, Jansen JA, Mikos AG (2003) rhBMP-2 release from injectable poly(DL-Lactic-co-glycolic Acid)/calcium-phosphate cement composites. J Bone Joint Surg, Am 85:75
Sachse A, Wagner A, Keller M, Wagner O, Wetzel WD, Layher F, Venbrocks RA, Hortschansky P, Pietraszczyk M, Wiederanders B, Hempel HJ, Bossert J, Horn J, Schmuck K, Mollenhauer J (2005) Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37(5):699–710
Sakiyama-Elbert SE, Hubbell JA (2000) Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 69(1):149–158
Samorezov JE, Headley EB, Everett CR, Alsberg E (2016) Sustained presentation of BMP-2 enhances osteogenic differentiation of human adipose-derived stem cells in gelatin hydrogels. J Biomed Mater Res Part A 104(6):1387–1397
Sarkar A, Tatlidede S, Scherer SS, Orgill DP, Berthiaume F (2011) Combination of stromal cell-derived factor-1 and collagen–glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice. Wound Repair Regen Off Publ Wound Healing Soc Eur Tissue Repair Soc 19(1):71–79
Schrier JA, DeLuca PP (2001) Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release. AAPS PharmSciTech 2(3):66–72
Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T, Riecken EO (1998) Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 114(1):139–152
Seeherman HLR, Bouxsein M, Kim H, Li j, Smith-Adaline EA, Aiolova M, Wozney JM (2006) rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg 88-A(1):144–160
Shah NJ, Macdonald ML, Beben YM, Padera RF, Samuel RE, Hammond PT (2011) Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 32(26):6183–6193
Sharma M, Afrin F, Satija N, Tripathi RP, Gangenahalli GU (2011) Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 20(6):933–946
Shen W, Chen X, Chen J, Yin Z, Heng BC, Chen W, Ouyang H-W (2010) The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk- collagen sponge scaffold on tendon regeneration. Biomaterials 31(28):7239–7249
Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM (2014) Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomed 9(1):273–287
Shi Z, Neoh KG, Kang ET, Poh CK, Wang W (2009) Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules 10(6):1603–1611
Shi W, Ji Y, Zhang X, Shu S, Wu Z (2011) Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery. J Pharm Sci 100(3):886–895
Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ (2004) Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35(2):562–569
Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2. Double-blind, randomized, controlled clinical trial. Circulation 105(7):788–793
Sinha VR, Trehan A (2003) Biodegradable microspheres for protein delivery. J Control Release 90(3):261–280
Sneha Maroo KRVM (2014) Treatment of periodontal intrabony defects using β-TCP alone or in combination with rhPDGF-BB: a randomized controlled clinical and radiographic study. Periodontic Restor Dent 34(6):841–847
Steinmüller-Nethl D, Kloss FR, Najam-Ul-Haq M, Rainer M, Larsson K, Linsmeier C, Köhler G, Fehrer C, Lepperdinger G, Liu X, Memmel N, Bertel E, Huck CW, Gassner R, Bonn G (2006) Strong binding of bioactive BMP-2 to nanocrystalline diamond by physisorption. Biomaterials 27(26):4547–4556
Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N (2006) Additive enhancement of implant fixation following combined treatment with rhTGF-β2 and rhBMP-2 in a canine model. J Bone Joint Surg Ser A 88(4):806–817
Sun W, Sun C, Lin H, Zhao H, Wang J, Ma H, Chen B, Xiao Z, Dai J (2009) The effect of collagen-binding NGF-β on the promotion of sciatic nerve regeneration in a rat sciatic nerve rush injury model. Biomaterials 30(27):4649–4656
Sun W, Lin H, Chen B, Zhao W, Zhao Y, Xiao Z, Dai J (2010) Collagen scaffolds loaded with collagen-binding NGF-β accelerate ulcer healing. J Biomed Mater Res Part A 92(3):887–895
Swiderska KW, Szlachcic A, Czyrek A, Zakrzewska M, Otlewski J (2017) Site-specific conjugation of fibroblast growth factor 2 (FGF2) based on incorporation of alkyne-reactive unnatural amino acid. Bioorg Med Chem 25(14):3685–3693
Takagi G, Miyamoto M, Tara S, Takagi I, Takano H, Yasutake M, Tabata Y, Mizuno K (2011) Controlled-release basic fibroblast growth factor for peripheral artery disease: comparison with autologous bone marrow-derived stem cell transfer. Tissue Eng Part A 17(21–22):2787–2794
Takahashi T, Tominaga T, Watabe N, Toshimitu A, Yokobori J, Sasada H, Yoshimoto T (1999) Use of porous hydroxyapatite graft containing recombinant human bone morphogenetic protein-2 for cervical fusion in a caprine model. J Neurosurg Spine 90(2):224–230
Tan XW, Lakshminarayanan R, Liu SP, Goh E, Tan D, Beuerman RW, Mehta JS (2012) Dual functionalization of titanium with vascular endothelial growth factor and β-defensin analog for potential application in keratoprosthesis. J Biomed Mater Res Part B Appl Biomater 100B(8):2090–2100
Tanaka H, Sugita T, Yasunaga Y, Shimose S, Deie M, Kubo T, Murakami T, Ochi M (2005) Efficiency of magnetic liposomal transforming growth factor-beta 1 in the repair of articular cartilage defects in a rabbit model. J Biomed Mater Res Part A 73A(3):255–263
Tatekawa Y, Kawazoe N, Chen G, Shirasaki Y, Komuro H, Kaneko M (2010) Tracheal defect repair using a PLGA–collagen hybrid scaffold reinforced by a copolymer stent with bFGF- impregnated gelatin hydrogel. Pediatr Surg Int 26(6):575–580
Thakare KDV (2012) Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β- TCP for the treatment of infrabony periodontal defects: clinical and radiographic results. Int J Periodontic Restor Dent 32(6):689–696
Theiss HD, Brenner C, Engelmann MG, Zaruba M-M, Huber B, Henschel V, Mansmann U, Wintersperger B, Reiser M, Steinbeck G, Franz W-M (2010) Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) — rationale, design and first interim analysis. Int J Cardiol 145(2):282–284
Thomas TP, Shukla R, Kotlyar A, Liang B, Ye JY, Norris TB, Baker JR (2008) Dendrimer−epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 9(2):603–609
Tong X, Lee S, Bararpour L, Yang F (2015) Long-term controlled protein release from poly(ethylene glycol) hydrogels by modulating mesh size and degradation. Macromol Biosci 15(12):1679–1686
Toth JM, Boden SD, Burkus JK, Badura JM, Peckham SM, McKay WF (2009) Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein–2 in a cancellous bone environment. Spine 34(6):539–550
Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424
Tufvesson E, Westergren-Thorsson G (2002) Tumour necrosis factor-α interacts with biglycan and decorin. FEBS Lett 530(1-3):124–128
Tuszynski MH, Yang JH, Barba D et al (2015) Nerve growth factor gene therapy: activation of neuronal responses in alzheimer disease. JAMA Neurol 72(10):1139–1147
Upton Z, Cuttle L, Noble A, Kempf M, Topping G, Malda J, Xie Y, Mill J, Harkin DG, Kravchuk O, Leavesley DI, Kimble RM (2008) Vitronectin: growth factor complexes hold potential as a wound therapy approach. J Investig Dermatol 128(6):1535–1544
Vanden Berg-Foels WS (2013) In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev 20(1):28–39
Vilchis-Landeros MM, Montiel JL, Mendoza V, Mendoza-Hernandez G, Lopez-Casillas F (2001) Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent. Biochem J 355(1):215–222
Vulic K, Shoichet MS (2014) Affinity-based drug delivery systems for tissue repair and regeneration. Biomacromolecules 15(11):3867–3880
Walchli T, Wacker A, Frei K, Regli L, Schwab ME, Hoerstrup SP, Gerhardt H, Engelhardt B (2015) Wiring the vascular network with neural cues: a CNS perspective. Neuron 87(2):271–296
Wang RN, Green J, Wang Z, Deng Y, Qiao M, Peabody M, Zhang Q, Ye J, Yan Z, Denduluri S, Idowu O, Li M, Shen C, Hu A, Haydon RC, Kang R, Mok J, Lee MJ, Luu HL, Shi LL (2014) Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis 1(1):87–105
Wang S, Ju W, Shang P, Lei L, Nie H (2015) Core-shell microspheres delivering FGF-2 and BMP- 2 in different release patterns for bone regeneration. J Mater Chem B 3(9):1907–1920
Wang Z, Wang Z, Lu WW, Zhen W, Yang D, Peng S (2017) Novel biomaterial strategies for controlled growth factor delivery for biomedical applications. Npg Asia Mater 9:e435
Wei G, Jin Q, Giannobile WV, Ma PX (2007) The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28(12):2087–2096
Wells A, Nuschke A, Yates CC (2016) Skin tissue repair: matrix microenvironmental influences. Matrix Biol 49:25–36
Windisch P, Stavropoulos A, Molnár B, Szendröi-Kiss D, Szilágyi E, Rosta P, Horváth A, Capsius B, Wikesjö UME, Sculean A (2012) A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy. Clin Oral Investig 16(4):1181–1189
Witsch E, Sela M, Yarden Y (2010) Roles for growth factors in cancer progression. Physiol (Bethesda) 25(2):85–101
Wu C, Fan W, Chang J, Xiao Y (2013) Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor. J Biomater Appl 28(3):367–374
Xian CJ (2007) Roles of epidermal growth factor family in the regulation of postnatal somatic growth. Endocr Rev 28(3):284–296
Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T, Hou X (2005) Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: in vitro and in vivo studies. J Control Release 105(1):106–119
Xie W, Zhang K, Cui B (2012) Functional characterization and axonal transport of quantum dot labeled BDNF. Integr Biol 4(8):953–960
Yamachika E, Tsujigiwa H, Shirasu N, Ueno T, Sakata Y, Fukunaga J, Mizukawa N, Yamada M, Sugahara T (2009) Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads. J Biomed Mater Res Part A 88A(3):599–607
Yang P, Wang C, Shi Z, Huang X, Dang X, Li X, Lin S-F, Wang K (2010) rhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. J Biomed Mater Res Part A 92A(2):626–640
Yang HS, La W-G, Cho Y-M, Shin W, Yeo G-D, Kim B-S (2012) Comparison between heparin- conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Exp Mol Med 44:350
Ye L, Zhang W, Su L-P, Haider HK, Poh K-K, Galupo MJ, Songco G, Ge R-W, Tan H-C, Sim EKW (2011) Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair. Biomaterials 32(9):2424–2431
Yoon JJ, Chung HJ, Lee HJ, Park TG (2006) Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 79((4):934–942
Zhang S, Uludağ H (2009) Nanoparticulate systems for growth factor delivery. Pharm Res 26(7):1561
Zhang J, Postovit LM, Wang D, Gardiner RB, Harris R, Abdul M, Thomas A (2009) In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release. Nanoscale Res Lett 4(11):1297–1302
Zhang H, Migneco F, Lin C-Y, Hollister SJ (2010) Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A 16(11):3441–3448
Zhang C, Chen J, Feng C, Shao X, Liu Q, Zhang Q, Pang Z, Jiang X (2014) Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer’s disease. Int J Pharm 461(1):192–202
Zhao Y-Z, Li X, Lu C-T, Lin M, Chen L-J, Xiang Q, Zhang M, Jin R-R, Jiang X, Shen X-T, Li X-K, Cai J (2014) Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats. Nanomed Nanotechnol Biol Med 10(4):755–764
Zhou X, Feng W, Qiu K, Chen L, Wang W, Nie W, Mo X, He C (2015) BMP-2 derived peptide and dexamethasone incorporated mesoporous silica nanoparticles for enhanced osteogenic differentiation of bone mesenchymal stem cells. ACS Appl Mater Interfaces 7(29):15777–15789
Zisch AH, Lutolf MP, Hubbell JA (2003) Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12(6):295–310
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Atienza-Roca, P., Cui, X., Hooper, G.J., Woodfield, T.B.F., Lim, K.S. (2018). Growth Factor Delivery Systems for Tissue Engineering and Regenerative Medicine. In: Chun, H., Park, C., Kwon, I., Khang, G. (eds) Cutting-Edge Enabling Technologies for Regenerative Medicine. Advances in Experimental Medicine and Biology, vol 1078. Springer, Singapore. https://doi.org/10.1007/978-981-13-0950-2_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-0950-2_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0949-6
Online ISBN: 978-981-13-0950-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)